Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Filer	Latest Filing Date	Share-Type	Shares	Market Value	Change
Kahn Brothers Group Inc	2022-11-15	Shares	1.44M	8.79M	1.44M
Keystone Financial Planning...	2022-10-12	Shares	238.84K	1.46M	238.84K
Pathstone Family Office, Llc	2022-11-14	Shares	17.79K	108K	17.79K

NYSE:HLN

Haleon plc

Last Close

10.09

30/08 20:00

Market Cap

39.86B

Beta: -

Volume Today

3.16M

Avg: 4.82M

PE Ratio

24.59

PFCF: -

Dividend Yield

1.56%

Payout:0%

Institutional trades

Institutional Ownership

Current holdings institutionals